Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE28.0700
- TODAY'S CHANGE (%)0.3700 (1.3357%)
- Bid / Lots27.8800/ 10
- Ask / Lots28.6500/ 1
- Open / Previous Close27.7100 / 27.7000
- Day Range
- 52 Week Range
- Volume3,080,807
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 27777 | 27.89 |
| 09:34 ET | 735 | 27.96 |
| 09:36 ET | 2014 | 27.83 |
| 09:38 ET | 516 | 27.91 |
| 09:39 ET | 966 | 27.8808 |
| 09:41 ET | 2875 | 27.8409 |
| 09:43 ET | 600 | 27.85 |
| 09:45 ET | 2958 | 27.86 |
| 09:48 ET | 4476 | 27.82 |
| 09:50 ET | 700 | 27.86 |
| 09:52 ET | 1290 | 27.885 |
| 09:54 ET | 1545 | 27.89 |
| 09:56 ET | 1777 | 27.93 |
| 09:57 ET | 700 | 27.93 |
| 09:59 ET | 900 | 27.94 |
| 10:01 ET | 2504 | 27.9201 |
| 10:03 ET | 2564 | 27.93 |
| 10:06 ET | 4042 | 27.92 |
| 10:08 ET | 4643 | 27.96 |
| 10:10 ET | 2538 | 27.985 |
| 10:12 ET | 1733 | 27.97 |
| 10:14 ET | 1000 | 27.96 |
| 10:15 ET | 628 | 27.965 |
| 10:17 ET | 1828 | 27.975 |
| 10:19 ET | 2934 | 27.965 |
| 10:21 ET | 967 | 27.965 |
| 10:24 ET | 4410 | 27.89 |
| 10:26 ET | 2879 | 27.915 |
| 10:28 ET | 1212 | 27.905 |
| 10:30 ET | 1678 | 27.91 |
| 10:32 ET | 3677 | 27.905 |
| 10:33 ET | 1714 | 27.91 |
| 10:35 ET | 18394 | 27.925 |
| 10:37 ET | 3728 | 27.905 |
| 10:39 ET | 21945 | 27.915 |
| 10:42 ET | 24118 | 27.95 |
| 10:44 ET | 15759 | 27.955 |
| 10:46 ET | 9031 | 27.95 |
| 10:48 ET | 20625 | 27.965 |
| 10:50 ET | 5550 | 27.965 |
| 10:51 ET | 17287 | 27.975 |
| 10:53 ET | 77766 | 28.0075 |
| 10:55 ET | 4384 | 28.01 |
| 10:57 ET | 11634 | 28.01 |
| 11:00 ET | 2086 | 28.01 |
| 11:02 ET | 1900 | 28.005 |
| 11:04 ET | 1249 | 28.03 |
| 11:06 ET | 755 | 28.035 |
| 11:08 ET | 2558 | 28.04 |
| 11:09 ET | 2539 | 28.04 |
| 11:11 ET | 4510 | 28.05 |
| 11:13 ET | 14116 | 28.025 |
| 11:15 ET | 200 | 28.02 |
| 11:18 ET | 1300 | 28.0275 |
| 11:20 ET | 933 | 28.035 |
| 11:22 ET | 2916 | 28.04 |
| 11:24 ET | 2352 | 28.005 |
| 11:26 ET | 1461 | 28.02 |
| 11:27 ET | 1639 | 28.045 |
| 11:29 ET | 300 | 28.04 |
| 11:31 ET | 100 | 28.05 |
| 11:33 ET | 2375 | 28.04 |
| 11:36 ET | 1723 | 28.04 |
| 11:38 ET | 1012 | 28.045 |
| 11:40 ET | 735 | 28.04 |
| 11:42 ET | 1898 | 28.02 |
| 11:44 ET | 2093 | 28.02 |
| 11:45 ET | 6048 | 27.995 |
| 11:47 ET | 4270 | 27.995 |
| 11:49 ET | 4313 | 27.9902 |
| 11:51 ET | 3102 | 28.005 |
| 11:54 ET | 2410 | 28.03 |
| 11:56 ET | 3034 | 28.03 |
| 11:58 ET | 800 | 28.02 |
| 12:00 ET | 206979 | 28.05 |
| 12:02 ET | 8096 | 28.03 |
| 12:03 ET | 727 | 28.0495 |
| 12:05 ET | 3486 | 28.0697 |
| 12:07 ET | 6666 | 27.985 |
| 12:09 ET | 14470 | 27.99 |
| 12:12 ET | 2351 | 28.005 |
| 12:14 ET | 3647 | 27.975 |
| 12:16 ET | 1315 | 27.955 |
| 12:18 ET | 5658 | 27.955 |
| 12:20 ET | 1300 | 27.98 |
| 12:21 ET | 4564 | 27.95 |
| 12:23 ET | 1829 | 27.965 |
| 12:25 ET | 1943 | 27.965 |
| 12:27 ET | 5671 | 27.965 |
| 12:30 ET | 10563 | 28.005 |
| 12:32 ET | 300 | 28.025 |
| 12:34 ET | 5805 | 28.039 |
| 12:36 ET | 5799 | 28.0592 |
| 12:38 ET | 2408 | 28.07 |
| 12:39 ET | 3330 | 28.035 |
| 12:41 ET | 700 | 28.02 |
| 12:43 ET | 5135 | 28.015 |
| 12:45 ET | 3366 | 27.995 |
| 12:48 ET | 4956 | 28.005 |
| 12:50 ET | 2539 | 28.015 |
| 12:52 ET | 2669 | 27.98 |
| 12:54 ET | 1976 | 27.975 |
| 12:56 ET | 2499 | 27.99 |
| 12:57 ET | 2025 | 27.995 |
| 12:59 ET | 5168 | 27.985 |
| 01:01 ET | 528 | 27.98 |
| 01:03 ET | 2333 | 27.985 |
| 01:06 ET | 1133 | 27.965 |
| 01:08 ET | 3764 | 27.95 |
| 01:10 ET | 8331 | 27.95 |
| 01:12 ET | 2338 | 27.92 |
| 01:14 ET | 7451 | 27.92 |
| 01:15 ET | 3832 | 27.925 |
| 01:17 ET | 5568 | 27.955 |
| 01:19 ET | 4122 | 27.98 |
| 01:21 ET | 1649 | 27.985 |
| 01:24 ET | 2198 | 27.98 |
| 01:26 ET | 2425 | 27.98 |
| 01:28 ET | 200 | 27.98 |
| 01:30 ET | 4962 | 27.995 |
| 01:32 ET | 1504 | 28 |
| 01:33 ET | 2001 | 28.015 |
| 01:35 ET | 4197 | 28.01 |
| 01:37 ET | 2086 | 28.005 |
| 01:39 ET | 3771 | 28 |
| 01:42 ET | 3570 | 27.98 |
| 01:44 ET | 1700 | 27.96 |
| 01:46 ET | 1760 | 27.955 |
| 01:48 ET | 18459 | 28.02 |
| 01:50 ET | 3765 | 28.035 |
| 01:51 ET | 10010 | 28 |
| 01:53 ET | 6178 | 28.005 |
| 01:55 ET | 1882 | 27.975 |
| 01:57 ET | 700 | 27.97 |
| 02:00 ET | 3067 | 27.98 |
| 02:02 ET | 2140 | 27.965 |
| 02:04 ET | 7246 | 27.95 |
| 02:06 ET | 4038 | 27.96 |
| 02:08 ET | 300 | 27.965 |
| 02:09 ET | 5084 | 27.97 |
| 02:11 ET | 6360 | 27.925 |
| 02:13 ET | 21334 | 27.92 |
| 02:15 ET | 17857 | 27.905 |
| 02:18 ET | 12777 | 27.89 |
| 02:20 ET | 9573 | 27.84 |
| 02:22 ET | 83434 | 27.87 |
| 02:24 ET | 10334 | 27.895 |
| 02:26 ET | 800 | 27.9 |
| 02:27 ET | 5098 | 27.905 |
| 02:29 ET | 5349 | 27.905 |
| 02:31 ET | 4032 | 27.88 |
| 02:33 ET | 6457 | 27.9 |
| 02:36 ET | 7932 | 27.88 |
| 02:38 ET | 6432 | 27.89 |
| 02:40 ET | 2526 | 27.95 |
| 02:42 ET | 5778 | 27.98 |
| 02:44 ET | 7355 | 27.99 |
| 02:45 ET | 7399 | 28.015 |
| 02:47 ET | 123354 | 28.07 |
| 02:49 ET | 6810 | 28.16 |
| 02:51 ET | 6328 | 28.16 |
| 02:54 ET | 4618 | 28.13 |
| 02:56 ET | 7030 | 28.12 |
| 02:58 ET | 7118 | 28.17 |
| 03:00 ET | 5322 | 28.18 |
| 03:02 ET | 2520 | 28.2 |
| 03:03 ET | 9335 | 28.15 |
| 03:05 ET | 6147 | 28.175 |
| 03:07 ET | 3100 | 28.195 |
| 03:09 ET | 7032 | 28.18 |
| 03:12 ET | 5249 | 28.18 |
| 03:14 ET | 5057 | 28.175 |
| 03:16 ET | 9403 | 28.155 |
| 03:18 ET | 7259 | 28.13 |
| 03:20 ET | 7091 | 28.14 |
| 03:21 ET | 11665 | 28.105 |
| 03:23 ET | 15077 | 28.125 |
| 03:25 ET | 10899 | 28.14 |
| 03:27 ET | 116085 | 28.145 |
| 03:30 ET | 8689 | 28.135 |
| 03:32 ET | 6723 | 28.105 |
| 03:34 ET | 6210 | 28.095 |
| 03:36 ET | 14090 | 28.06 |
| 03:38 ET | 16822 | 28.06 |
| 03:39 ET | 10591 | 28.025 |
| 03:41 ET | 33282 | 28.03 |
| 03:43 ET | 26382 | 28.005 |
| 03:45 ET | 44835 | 28.005 |
| 03:48 ET | 14389 | 27.985 |
| 03:50 ET | 19203 | 28.05 |
| 03:52 ET | 42496 | 28.025 |
| 03:54 ET | 24078 | 28.005 |
| 03:56 ET | 100973 | 28.055 |
| 03:57 ET | 77737 | 28.08 |
| 03:59 ET | 67825 | 28.07 |
Apr 19, 2024
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024, from 8:15AM ET on Friday Apr 19, 2024 by Dow Jones
8:15AM ET on Friday Apr 19, 2024 by Dow Jones
Apr 17, 2024
Royalty Pharma Declares Second Quarter 2024 Dividend, from 8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:15AM ET on Wednesday Apr 17, 2024 by Dow JonesPress Release: Royalty Pharma Declares Second Quarter 2024 Dividend, from 8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 12, 2024
DJ Royalty Pharma Is Maintained at Buy by B of A Securities, from 8:11AM ET on Friday Apr 12, 2024 by Dow Jones
8:11AM ET on Friday Apr 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 16.5B | 11.1x | +1.83% |
Amneal Pharmaceuticals Inc | 1.9B | -19.6x | --- |
Catalent Inc | 10.1B | -7.8x | --- |
Jazz Pharmaceuticals PLC | 6.9B | 18.0x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.6B | -43.3x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.5B |
|---|---|
Revenue (TTM) | $2.4B |
Shares Outstanding | 597.4M |
Dividend Yield | 2.99% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.47 |
EPS | $2.54 |
Book Value | $14.61 |
P/E Ratio | 11.1x |
Price/Sales (TTM) | 7.0 |
Price/Cash Flow (TTM) | 9.7x |
Operating Margin | 63.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
